| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.0095 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |